The hypoxia-inducible transcription factor HIF-1 is appreciated as a promising target for cancer therapy. However, conditional deletion of HIF-1 and HIF-1 target genes in cells of the tumor microenvironment can result in accelerated tumor growth, calling for a detailed characterization of the cellular context to fully comprehend HIF-1's role in tumorigenesis. We dissected cell type-specific functions of HIF-1 for intestinal tumorigenesis by lineagerestricted deletion of the Hif1a locus. Intestinal epithelial cell-specific Hif1a loss reduced activation of wnt/β-catenin, tumor-specific metabolism and inflammation, significantly inhibiting tumor growth. Deletion of Hif1a in myeloid cells reduced the expression of fibroblast-activating factors in tumor-associated macrophages resulting in decreased abundance of tumor-associated fibroblasts and robustly reduced tumor formation.
Introduction
Colorectal cancer (CRC) ranks as the third most commonly diagnosed tumor in both sexes in the western world, causing a substantial amount of cancer-associated morbidity and mortality (1) . In the last decade, molecular-targeted drugs have -in combination with conventional therapies-resulted in improved outcome of CRC patients (2) . However, as also noted frequently for other solid tumors, these new generation treatments rarely result in improved outcome, but rather benefit small subgroups of CRC patients (3) . Taken together, an urgent need to identify novel therapy targets exists, demonstrating the necessity for detailed characterization of the molecular CRC pathogenesis.
The hypoxia-inducible transcription factor 1 (HIF-1) is positively associated with the malignant progression of various tumor entities (4) (5) (6) (7) . While the role of HIF-1 for the pathogenesis of CRC has been addressed by different groups, results are conflicting and the precise function of HIF-1 for intestinal tumorigenesis remains elusive. Stabilization of HIF-1α, the regulatory component of HIF-1, in human CRC has been reported via immunohistochemistry, suggesting a pro-tumorigenic function (8) (9) (10) . In line with these findings, inhibition of HIF-1α in human CRC cell lines resulted in reduced xenograft growth (11, 12) . Furthermore, pharmaceutical inhibition of HIF-1α led to diminished growth of autochtonous as well as allograft murine CRC models via reduced angiogenesis and macrophage infiltration (13) . On the other hand, transgenic activation of HIF-1 in intestinal epithelial cells (IEC) remained without effect on tumor formation in murine models of sporadic and colitis-associated colon cancer (14, 15) . Moreover, IEC-specific loss of Hif1a did not affect tumor frequency in a chemical model of proximal intestinal tumorigenesis (16) . These results illustrate that the precise role of HIF-1 for intestinal tumorigenesis remains elusive thus far.
While HIF-1 is widely appreciated as a promising target for cancer therapy (17) , conditional deletion of HIF-1 and HIF-1 target genes in cells of the tumor microenvironment can result in accelerated tumor growth (18) (19) (20) . Against this background, a comprehensive analysis of HIF-1's role in tumorigenesis in order to translate the findings into the clinic can only be achieved by considering the cell-and tissue-specific context. Here, we present a detailed deconstruction of HIF-1's role in CRC initiation and progression in IEC-and myeloid cellspecific Hif1a knock-out mice (21, 22) using two murine tumor models: Chemically-induced colon tumors (AOM/DSS (combination of azoxymethane plus dextran sulfate sodium for colitis-associated carcinogenesis) (23) ) and the genetic APC min model (24) . This experimental approach enabled us to address the role of HIF-1 in neoplastic epithelial cells as well as in innate immune cells of the tumor microenvironment. We were able to unravel numerous specialized functions of HIF-1. In IECs, HIF-1 serves to induce inflammation, control wnt/β-catenin activity and regulate tumor-specific metabolism. In addition, we identified myeloid HIF-1 as essential for the activation of tumor-associated fibroblasts. Of note, intratumoral hypoxia was a rare event, pointing towards an importance of hypoxiaindependent, i.e. non-canonical HIF-1 stabilization for intestinal tumorigenesis (25) .
Collectively, our data show that HIF-1 is a pivotal pro-tumorigenic factor, controlling key oncogenic programs in both the epithelial tumor compartment and the tumor microenvironment.
Results

Epithelial Hif1a controls intestinal tumor growth on multiple levels
IEC-specific loss of Hif1a (termed Hif1a IEC ) was established by breeding villin-cre mice (26) with animals harbouring floxed Hif1a alleles (22) . Conditional Hif1a deletion was characterized on various levels and found to be highly efficient ( Figure S1A ). Tumor size in both the AOM/DSS and APC min model was significantly decreased in Hif1a IEC mice ( Figure   1A ). We sought to identify the underlying molecular mechanisms and first characterized the activity of the wnt/β-catenin pathway, the central oncogenic driver of CRC. As can be seen in figure 1B -D, wnt-dependent gene expression is significantly reduced in adenomas of Hif1a IEC mice in both tumor models, suggesting a functional role of HIF-1 for wnt/β-catenin activity in this setting. Next, we addressed the role of Hif1a for tumor-specific glucose metabolism as metabolic reprogramming represents an emerging hallmark of cancer and several glycolytic enzymes are transcriptionally controlled by HIF-1 (27) . Mass spectrometry-based analysis of intratumoral glucose levels, routing of Figure S2 ), organoids were subjected to different pro-inflammatory stimuli. These experiments nicely confirmed that the proinflammatory response of IECs critically depends on Hif1a ( Figure 2E ). Taken together, these data point towards a complex role for Hif1a in IECs during intestinal tumor formation, comprising inflammation, wnt/β-catenin activity and metabolic reprogramming.
Hif1a in myeloid cells controls intestinal tumor formation without affecting inflammation
Macrophages in the tumor microenvironment exert a number of tumor-supporting functions and are positively associated with the malignant phenotype (29) . We and others have shown that Hif1a is of pivotal importance for various aspects of macrophage function (21, 30) .
Against this background, we sought to characterize the role of Hif1a for intestinal tumor formation in macrophages. We found that myeloid cell-specific loss of Hif1a (termed Hif1a MC ) resulted in a highly significant reduction of both tumor number and size (Fig. 3A) . In order to identify the underlying mechanisms, we first analyzed the inflammatory response. Rather unexpectedly, various assays of inflammation (e.g. determination of weight loss (Fig. 3B ), disease activity index (Fig. 3C) ) as well as gene expression and protein production of established pro-inflammatory markers (Fig. 3D , E, F)) failed to show a difference of inflammatory activity between wildtype and Hif1a MC mice.
Hif1a-deficient tumor-associated macrophages migrate and function normally
Next, we determined intratumoral macrophage numbers via immunohistochemistry (IHC).
While macrophage abundance was clearly greater in adenomas compared to surrounding normal mucosa (not shown), no difference was detectable between the genotypes ( Figure   4A ). Intestinal leukocyte subsets were subsequently analyzed in more detail by flow cytometry. Tumor-bearing mice displayed a prominent increase in CD11c+ macrophages and CD11b+ dendritic cells, while CD11c-macrophages were reduced. The changes in myeloid subsets were comparable between wildtype and Hif1a MC mice, except for a slightly more pronounced reduction of CD11c-intestinal macrophages in tumor-bearing Hif1a MC mice ( Figure 4B ). Intestinal lymphoid cell populations did not differ significantly between wildtype and Hif1a MC mice ( Figure 4B ). Notably, tumor-bearing animals showed typical alterations of extraintestinal myeloid cells (31) , including increase of monocytes in blood and bone marrow and accumulation of Gr1+ CD11b+ myeloid-derived suppressor cells (MDSC) in bone marrow, but not spleen ( Figure S3 ). Extraintestinal myeloid cells did not differ between wildtype and Hif1a MC mice. Next, we decided to analyze the direct tumor-supporting action of macrophages as these cells secrete numerous pro-tumorigenic factors (32) . To this end, spheroids of APC min adenomas were stimulated with conditioned medium (CM) from primary murine macrophages. While we were able to detect a significant growth-promoting effect of macrophage CM, the loss of Hif1a did not affect the outcome ( Figure 4C ). As macrophages represent pivotal modulators of stem-like/progenitor cells (33) , which are critical drivers of colonic carcinogenesis (34), we decided to quantify these cells in our experimental setting.
Visualization of Lgr5 and Prox1, two established progenitor/stem-cell markers in intestinal tumors (35, 36) , demonstrated robust presence of these cells in AOM/DSS adenomas, albeit without differences between the genotypes ( Figure S4A ). Furthermore, we took into consideration that other cells of myeloid origin might underlie the reduced tumor formation in Hif1a MC mice. While mast cells can influence intestinal tumorigenesis under certain experimental conditions (37) , no difference in intratumoral abundance of this cell type was noted, arguing against a functional importance of mast cells in our setting ( Figure S4B ).
Hif1a in myeloid cells is essential for the activation of tumor-associated fibroblasts
Myeloid cells in the tumor microenvironment are known to interact with various cell types, including tumor-associated fibroblasts (TAF). These cells are abundant in human CRC and significantly impact on disease progression (38, 39) . TAFs were readily detectable via IHC in the stroma of APC min and AOM/DSS-induced adenomas ( Figure 5A ). Strikingly, deletion of Hif1a in myeloid cells resulted in greatly reduced numbers of TAFs in both tumor models ( Figure 5A ). This result pointed towards a crucial role of Hif1a in myeloid cells for TAF development. Interestingly, the importance of macrophages for fibroblast activation in the context of wound healing is well established (40, 41) . To analyze this further, we focussed on alternatively activated macrophages (AAM) given their central role in the control of organ fibrosis (40) . Expression of various pro-fibrotic genes in AAMs was readily detectable, but loss of Hif1a remained without effect ( Figure S5A ). To achieve experimental data that more closely resemble the in vivo situation, we analyzed pro-fibrotic factor expression in tumor-associated macrophages (TAM) directly isolated from intestinal adenomas. This approach indeed unravelled a central role of Hif1a in TAMs for the expression of various fibroblastactivating factors, e.g. COX-2, IGF-1, IL-1β, IL-6 and granulin ( Figure 5B ). In our analyses, the expression of TGF-β1, the archetypical pro-fibrotic factor, was constantly lower in Hif1a-deficient TAMs, but did not reach statistical significance ( Figure 5B ). As the activation of TGF-β is a complex and highly regulated process (42), we hypothesized that HIF-1α is of importance in this setting. Indeed, HIF-1α-deficient AAMs displayed reduced levels of bioactive TGF-β in the supernatant ( Figure 5C ), suggesting a functional importance of HIF-1α for TGF-β activity elicited by TAMs. Next, we addressed the role of Hif1a for macrophagemediated fibroblast proliferation (40, 43) . While conditioned medium from AAM enhanced survival of primary murine intestinal fibroblasts (MIFs), no difference between WT and Hif1a-null macrophages was detectable ( Figure S5B ). Finally, we sought to address the secretion of pro-tumorigenic cytokines, another tumor-promoting function of TAFs (44) . Stimulation of primary MIFs with conditioned medium from AAM induced gene expression of IL-6, HGF and epiregulin (Ereg), factors with established tumor-promoting activity in the intestine (45, 46) .
Of note, this effect was significantly reduced upon deletion of Hif1a in macrophages ( Figure   5D ).
Myeloid-mediated activation of TAF precursor cells depends on Hif1a
TAFs can originate from different cellular sources, amongst others pericytes, mesenchymal stems cells (MSCs) and fibrocytes (44) . We sought to investigate if macrophages are able to polarize these cell types into myofibroblasts and whether Hif1a is important in this setting.
Gli1-positive pericytes, marked by tdTomato expression (47) , as well as MSCs readily polarized into myofibroblasts after addition of macrophage conditioned medium (CM, Figure   6A and B). Intriguingly, HIF-1α was of central importance in this setting as the effect on pericytes was completely and that on MSCs partially abolished upon Hif1a deletion.
Fibrocytes are of myeloid origin, display features of monocytes as well as fibroblasts and contribute to fibrosis in various organs and tumors (48, 49) . We took advantage of an established protocol to generate fibrocytes ex vivo from splenic monocytes (50) . Of note, Hif1a-deficient monocytes displayed greatly reduced capacity for fibrocyte production ( Figure 6C ). Furthermore, the expression of various tumor-supporting factors in fibrocytes was found to be regulated by Hif1a ( Figure 6D ). Taken together, these results point to a hitherto unknown function of Hif1a for the activation of TAF precursor cells of different origin.
Non-canonical stabilization of HIF-1α predominates in murine intestinal tumors
The luminal cell layer of the colon is characterized by physiological hypoxia (51). Nuclear HIF-1α protein is readily detectable in luminal enterocytes ( Figure S6A ), suggesting hypoxiainduced HIF-1α protein stabilization in the gut under physiological conditions. Against this background, we sought to determine the relevance of hypoxia for HIF-1α protein stabilization in murine intestinal tumors. Intriguingly, hypoxic areas were detected only sporadically in AOM/DSS and APC min adenomas ( Figure 7A and B). This pattern of hypoxia was clearly not able to explain the pervasive stabilization of HIF-1α protein in both tumor types. Against this background it is relevant to note that hypoxia-independent means of HIF-1α protein stabilization have been identified and are gradually receiving more attention (25, 27) . As activation of various oncogenes has been shown to result in hypoxia-independent HIF-1 stabilization, we decided to investigate the role of oncogenes and tumor suppressor genes characteristic for colon cancer (27, 52) . To mimic the molecular events that instigate tumor formation in the APC min model, mice with inducible Apc deletion were analyzed (53) . Of note,
acute Apc loss resulted in enhanced HIF-1α protein stability ( Figure 7D ). To analyze the role of oncogene activation for HIF-1α stabilization, we took advantage of transgenic mice with inducible, epithelial-specific expression of oncogenes with relevance for CRC pathogenesis (54) . The strongest effect was noted for PIK3CA H1047R , the activation of which resulted in robust HIF-1α protein stabilization of the entire epithelial cell lining ( Figure 7E ). Activation of oncogenic KRAS or β-catenin resulted in localized HIF-1α stabilization in luminal epithelial cells ( Figure 7F ,G,A). These results point towards a functional role of key tumor suppressors and oncogenes regulating the Wnt/β-catenin, PI3K and MAPK cascades for non-canonical HIF-1α stabilization during intestinal tumor formation and progression.
Discussion
Here, we addressed the functional importance of HIF-1 for colon cancer in a cell type-specific manner, using transgenic mice harbouring either an intestinal epithelial cell-(Hif1a IEC ) or a myeloid cell-specific (Hif1a MC ) Hif1a deletion (21, 22, 26) . We found that Hif1a plays multiple non-redundant roles in these two key cell types of intestinal tumors. Our finding of reduced tumor growth in Hif1a IEC mice is in line with earlier reports showing Hif1a-dependent growth of human CRC xenografts (11, 12) . Also in line with our results, the group of Celeste Simon relaying oncogenic events to HIF-1α stabilization in this study. However, our data add a further layer of complexity to HIF-1α regulation, and suggest that hypoxia and HIF-1α stabilization can be uncoupled in cancer.
Methods
Animals and Mouse models
All mice were housed in a specific pathogen-free environment and were allowed to adapt for at least 7 days to housing conditions before starting an experiment. Mice were given tap water and standard rodent chow ad libitum and were housed at constant room temperature with a 12 hour light/dark cycle. The maximum FDG uptake in the lesion was scaled to the mean FDG uptake in the thigh muscles.
Metabolomics extraction
Colon samples were homogenized in two cycles with a 20 s long cooling phase on ice in between by Precellyse24 (Bertin Technologies, France). Volumes of the ice-cold extraction solution methanol-chloroform-water (all Sigma, 5:2:1 v/v/v) were adjusted to the sample weight (1 ml/50 mg tissue). Extraction solvent contained an internal extraction standard cinnamic acid (Sigma, 2 µg/ml). Colon extracts were incubated for 30 min at 4°C on a rotary wheel, and subsequently centrifuged for phase separation (15 min, maximum speed). Equal volumes of polar phase were selected from each sample separately and dried under vacuum. Extracts were stored at -25°C until continuing with the preparation for GC-MS measurement.
GC-MS sample preparation
Derivatization was carried out as described with modifications (68) . 
GC-MS measurement
Metabolite analysis was performed on a gas chromatography 
GC-MS data analysis
File processing and analysis was performed with the vendor software ChromaTOF Version 4.42 (LECO). Processing parameters: baseline offset of 1, peak width of 4 s, signal/ noise of 20, and peak smoothing of 11 data points. Retention indices were calculated based on retention index standards. The Golm Metabolome Database (GMD) provided mass spectra and retention information for peak identification (70) . Quantification of metabolites was done by external calibration as described in (69) .
Differentiation of murine fibrocytes
Murine fibrocytes were cultured and differentiated as described in detail before (50) . Briefly, 
Murine intestinal fibroblasts
Intestinal fibroblasts were isolated from murine intestine as described in detail before (72) . incubation, organoids or spheroids were disrupted and re-seeded in Matrigel. Two days later, organoids were used for experiments, in which they were treated with 450 ng/ml LPS or 100 ng/ml murine TNFα and exposed to hypoxia (1% O 2 ) for 6 hours before RNA isolation.
Spheroids were treated with 1:5 diluted BMDM supernatants directly after passaging and monitored for up to five days. Spheroid diameter and number were calculated by evaluation of microscopic pictures using ImageJ software.
Isolation of F4/80+ cells from intestinal adenomas
Small intestinal adenomas were isolated from 120 days old APC min mice. The tissue was cut into small pieces and digested with Collagenase C and DNase. For further disruption, it was pulled through 18G and 22G needles. Cells were collected through a 70 µm cell strainer and incubated in serum-containing buffer to avoid unspecific antibody binding. In the next step, cells were labeled with biotinylated anti-F4/80 antibody (BioLegend) before magnetic Streptavidin MicroBeads (Miltenyi, Bergisch Gladbach, Germany) were added. Thereafter, F4/80-positive cells were selected by magnetic separation using LS columns (Miltenyi, Bergisch Gladbach, Germany) and finally dissolved in PeqGold RNA Pure reagent (Peqlab, Erlangen, Germany) for RNA isolation.
RNA extraction and quantitative PCR analysis
Intestinal tissue was disrupted and pulverized with a TissueLyser II (Qiagen, Hilden, Germany). Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and QIAshredder spin columns (Qiagen) according to the manufacturer's instructions. The yield and purity of RNA were determined spectrophotometrically. RNA integrity was checked by MOPS buffered denaturizing RNA gel electrophoresis and only samples with a 28S/18S ratio of at least 1.8
were included in the qPCR study. 
Immunohistochemistry
Immunohistochemical analysis was conducted on formalin-fixed paraffin-embedded tissues.
For histopathological evaluation, intestinal sections were stained with hematoxylin and eosin and mucosal inflammation was graded as described (66) . Intestinal sections were also stained with antibodies specific for F4/80 (Bio-Rad, Hemel Hempstead, UK), FSP-1 (Dako, Hamburg, Germany), HIF-1α (Cayman Chemical, Ann Arbor, USA), αSMA (Merck Millipore, Darmstadt, Germany) and ZO-1 (Thermo Fisher Scientific, Waltham, USA). The antibodyantigen complexes were detected using biotinylated donkey anti-rat and donkey anti-rabbit secondary antibodies (Dianova, Hamburg, Germany) and the Dako REAL Detection System (Dako). Sections were counterstained with hematoxylin. Immunohistochemical detection of HIF-1α was performed as previously described (77) . For the immunohistochemical assessment of hypoxic areas, the Hypoxyprobe-1 Kit (Hypoxyprobe Inc., Burlington, USA) was used as described before (78) . Tumor-associated macrophage abundance was determined by quantification of F4/80+ cells in at least 5 random fields of view.
Multiplex immunohistochemistry
Paraffin sections were deparaffinized and rehydrated according to standard protocols.
Subsequently, the sections were fixed by 10 min incubation in 3.5% formalin. 
Flow cytometric analyses of murine leukocyte populations
Small intestine was rinsed thoroughly and incubated in buffer containing EDTA to remove the mucus. Cells were minced and digested with type IV collagenase (Cellsystems). Blood was taken from the right ventricle. Small intestine, blood, bone marrow, and spleen cells were subjected to red blood cell lysis using Pharm Lyse (BD Biosciences, San Jose, USA). Flow cytometric analysis was done as described in detail before (79 
Study approval
Experimentation and transgenic animal generation was approved by authorities in Berlin (Landesamt für Gesundheit und Soziales: G0004/07, G0185/09, G0143/14). by unpaired Student's t test.
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